4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-14-002289
CIK 0001316175operating
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 9:58 PM ET
Size
9.9 KB
Accession
0001214659-14-002289
Insider Transaction Report
Form 4
Hislop Colin
Sr. VP, Cardiovasc. Prod.
Transactions
- Tax Payment
Common Stock
2014-03-25−3,323→ 20,283 total - Award
Common Stock
2014-03-25+3,864→ 24,147 total - Award
Stock option (right to buy)
2014-03-25+12,871→ 12,871 totalExercise: $3.30Exp: 2024-03-25→ Common Stock (12,871 underlying)
Holdings
- 1,897(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Shares forfeited in lieu of payment of tax liability in connection with the vesting of 7,392 performance shares, which represent the portion of the Reporting Person's 2012 performance share award.
- [F2]Shares have been adjusted to reflect the Issuer?s 1-for -8 reverse stock split effectuated July 15, 2013.
- [F3]Includes 5,594 shares acquired under the Issuer?s 2010 Employee Stock Purchase Plan on June 30 2013 .
- [F4]Award of Restricted Stock Units under the Issuer's 2013 Stock Option and Incentive Plan that vest immediately on March 25, 2014.
- [F5]Not applicable
- [F6]The Stock Option vests immediately on March 25, 2014.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 9:58 PM ET
- Size
- 9.9 KB